Please provide your email address to receive an email when new articles are posted on . Concomitant proton pump inhibitor plus ticagrelor monotherapy after PCI does not increase risk for all-cause ...
The benefit of percutaneous coronary intervention (PCI) in patients with stable coronary artery disease and severe aortic stenosis who are undergoing transcatheter aortic-valve implantation (TAVI) ...
Chicago, IL - The time at which primary PCI is conducted influences outcome with regard to both time from symptom onset and the actual time and day of the procedure, according to two new studies ...
SAN FRANCISCO – OCTOBER 26, 2025 – New study results from a large international all-comer population of percutaneous coronary intervention (PCI) candidates found that utilizing a strategy of sirolimus ...
LONDON, England—Patients with stable coronary artery disease and severe aortic stenosis fare significantly better over the long term if revascularized with PCI before TAVI than if they are treated ...
Philips has signed a deal to acquire enhanced vascular imaging (EVI) product developer SpectraWAVE, expanding the Dutch medtech giant’s minimally invasive percutaneous coronary intervention (PCI) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback